Revenues

Revenues

No data

Revenue YoY Change

No data

Revenues

Concept

Expenses

Cost Of Revenues

No data

Gross Profit

No data

Gross Profit Margin

No data

Gross Profit

Concept

Selling, General & Admin Expense

No data

Research & Development

No data

Depreciation, Depletion & Amortization

No data

SGA Expense to Gross Profit Ratio

No data

R&D To Gross Profit Ratio

No data

DDA To Gross Profit Ratio

No data

Operating Expenses Total

No data

Operating Profits/Loss

No data

Operational Expenses

Concept

Interest Expenses

No data

Interest Expenses To Operating Income %

No data

Other Expense/Income

No data

Interest & Other Expense/Income

Concept

Income/Loss

Pretax Income

No data

Income Tax

No data

Net Profits/Loss

No data

Pretax Income YoY Change

No data

Income Tax Rate

No data

Net Profits/Loss YoY Change

No data

Basic EPS

No data

Net Income To Revenue Ratio

No data

Pretax & Net Income

Concept

Assets & Liabilities

Cash & Short-Term Investments

No data

Cash & Equivalents

No data

Cash To Operating Expenses Ratio

No data

Inventory

No data

Receivables

No data

Total Short-Term Assets

No data

Property, Plant And Equipment

No data

Long-Term Investments

No data

Total Long-Term Assets

No data

Total Assets

No data

Net Income To Total Assets Percentage

No data

Accounts Payable

No data

Short-Term Debt

No data

Long Term Debt Due

No data

Total Short-Term Liabilities

No data

Long-Term Debt

No data

Other Long-Term Liabilities

No data

Total Long-Term Liabilities

No data

Total Liabilities

No data

Short-Term To Long-Term Debt Ratio

No data

Short-Term Assets To Debt Ratio

No data

Long-Term Debt To Net Income Ratio

No data

Assets & Liabilities

Concept

Ownership

Basic Shares Outstanding

No data

Diluted Shares Outstanding

No data

Preferred Stock

No data

Treasury Stock Shares

No data

Stock Issuance & Repurchase

No data

Ownership Data

Concept

Return On Shareholders' Equity

No data

Book Value

No data

Free Cash Flow

No data

Free Cash Flow YoY

No data

Free Cash Flow Margin

No data

Dividends

Dividends

No data

Stock Price

Market Cap: $2.7249 Million

About CYduct Diagnostics, Inc.

CYduct Diagnostics, Inc. engages in the development and marketing of technology, applications, medical devices, and procedural techniques for screening, diagnosis, treatment, and management of disease and medical conditions. The company is headquartered in Westport, Connecticut. The company went IPO on 2001-06-21. The firm focuses on the women's healthcare market, primarily breast healthcare and wellness. The company is focused on breast health and wellness through testing methods. The company focuses to provide a technology platform that includes evidence-based personalized breast health risk assessment testing. The firm serves medical schools, hospitals and physicians to develop medical devices and procedural techniques for the screening, diagnosis, treatment and management of disease and medical conditions.

Industry: UNKNOWN Peers: ABBOTT LABORATORIES Advanced Biomedical Technologies Inc. Bionik Laboratories Corp. ThermoGenesis Holdings, Inc. Nuwellis, Inc. INVIVO THERAPEUTICS HOLDINGS CORP. ECGI Holdings, Inc. ENCISION INC Wellness Center USA, Inc.